Thor Medical ASA (TRMED) — Cash Flow-to-Debt Ratio
Latest as of December 2024:
0.00x
Thor Medical ASA (TRMED) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2024, meaning its operating cash flow of Nkr-5.74K could theoretically repay 0% of its total liabilities (Nkr77.30 Million) in one year. Explore TRMED cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
0.00x
Operating CF / Total Liabilities
Operating Cash Flow
Nkr-5.74K
NOK
Total Liabilities
Nkr77.30 Million
NOK
Data as of
Dec 2024
Most recent filing
Thor Medical ASA Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Thor Medical ASA across 6 annual periods. Also explore TRMED current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Thor Medical ASA (2019–2024)
Year-by-year debt coverage analysis for Thor Medical ASA. For market capitalisation and broader financial context, see TRMED market cap.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.31x | Nkr-23.70 Million | Nkr77.30 Million | ▲ +71.8% |
| 2023 | -1.09x | Nkr-64.09 Million | Nkr58.91 Million | ▲ +87.8% |
| 2022 | -8.93x | Nkr-409.08 Million | Nkr45.80 Million | ▼ -245.7% |
| 2021 | -2.58x | Nkr-403.46 Million | Nkr156.16 Million | ▲ +11.8% |
| 2020 | -2.93x | Nkr-398.21 Million | Nkr135.94 Million | ▲ +96.7% |
| 2019 | -89.83x | Nkr-410.62 Million | Nkr4.57 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.